Early Clinical Experience with Cabozantinib for Advanced Renal Cell Carcinoma in the UK: Real-World Treatment Pathways and Clinical Outcomes

Authors:

Abstract
No abstract available
Funding Information
  • Ipsen

This publication has 22 references indexed in Scilit: